Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2007
11/22/2007US20070269488 Hydrogel Nanocompsites for Ophthalmic Applications
11/22/2007US20070269487 Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System
11/22/2007US20070269429 Treatment with anti-erbb2 antibodies
11/22/2007CA2651765A1 A medicament containing a thiazole derivative as an active ingredient
11/22/2007CA2651646A1 Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1856259A1 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007CN101076590A Treatment of eye disorders characterized by an elevated intraocular pressure by sirnas
11/21/2007CN101074189A Styrene acid derivative and use in preparation of various blood-vessels target agent medicine
11/21/2007CN101073668A Antibody compositions for selectively inhibiting vegf
11/21/2007CN101073599A Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production
11/21/2007CN101073582A Chinese medicine for treating otitis media and rhinitis
11/21/2007CN101073562A Instant taurine eyes gel
11/21/2007CN101073556A Eyes preparation for divergent pupil and its making method
11/21/2007CN101073553A Cromolyn-sodium eyes gel
11/21/2007CN101073351A Memory-enhancing tea with brain-invigorating and vision-improving functions
11/20/2007US7297715 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297334 Anti-vegf antibodies
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/20/2007CA2171743C Nucleotide analogs
11/15/2007WO2007131012A1 12-aryl or heteroaryl prostaglandin analogs
11/15/2007WO2007130712A1 Substituted dipiperidine as ccr2 antagonists for the treatment of inflammatory diseases
11/15/2007WO2007130477A2 Delivery of ophthalmologic agents to the exterior or interior of the eye
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129111A1 Diazepine derivatives as 5-ht2a antagonists
11/15/2007WO2007128526A2 Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases
11/15/2007WO2007128461A1 Animal food composition comprising genistein and polyunsaturated fatty acids
11/15/2007WO2007128222A1 Vitreous administration of erythropoietin
11/15/2007WO2007109578A3 Substituted gamma lactams as prostaglandin ep2 agonists
11/15/2007WO2007106723A3 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
11/15/2007WO2007084332A3 Memantine for the normalization of visual acuity deficits
11/15/2007WO2006086456A3 Combination of organic compounds
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265353 Eye Drops for the Treatment of Dry Eye
11/15/2007US20070265341 Compositions and methods for treating eye disorders and conditions
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265319 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265285 Quinazolinone derivatives and their use as CB agonists
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265247 Method of reducing contact lens intolerance with non-drying antihistamines
11/15/2007US20070265234 Methods for stabilizing oxidatively unstable compositions
11/15/2007US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007CA2651194A1 Methods for treating neovascular diseases
11/15/2007CA2651022A1 12-aryl or heteroaryl prostaglandin analogs
11/15/2007CA2650952A1 Therapeutic compounds
11/15/2007CA2650877A1 Vitreous administration of erythropoietin
11/14/2007EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007EP1854787A1 Novel cyclic compound having quinolylalkylthio group
11/14/2007EP1854477A2 Compositions and methods for treating ophthalmic disorders
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853239A1 Use of zeaxanthin for the treatment of diseases of the peripheral retina
11/14/2007EP1853113A2 Revascularization of ischemic retinal tissue and screening method therefor
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007CN101072568A Product containing prostaglandin having fluorine atom in molecule
11/14/2007CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007CN101069742A Pancreatic kininogenase tablet and preparing method
11/14/2007CN101069720A Ready-made Chinese medicine ointment for treating near sightedness and glaucoma
11/14/2007CN101069532A Blended oil in which the ratio of linoleic acid and linolenic acid is 4:1
11/14/2007CN100348654C Medicinal composition for ophthal use containing acetylated hyaluronic acid
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348231C Medicine composition for resisting exogenous cold and high fever, and its preparing method
11/13/2007US7294753 Method for preparing anti-MIF antibodies
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294345 Otorhinological delivery device
11/13/2007CA2442483C 3-heterocyclylpropanohydroxamic acid pcp inhibitors
11/08/2007WO2007127844A2 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
11/08/2007WO2007126392A1 Antimicrobial peptides
11/08/2007WO2007125731A1 Soft contact lens solution, drug-sustained release soft contact lens prepared by using the solution
11/08/2007WO2007125720A1 Molecular chaperone expression inducer
11/08/2007WO2007125566A2 Use of probiotics in the prevention and treatment of allergic conjunctivitis
11/08/2007WO2007124674A1 Compositions for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders
11/08/2007WO2007090134A3 Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma
11/08/2007US20070259912 Polymorphic forms of a GABAA agonist
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259401 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007DE112005003183T5 Diazen-verbrückte Kronenether-Lithium-Verbindung und Verfahren zu ihrer Verwendung Diazene-bridged crown ether-lithium compound and methods for their use
11/08/2007CA2823767A1 Abnormal cannabidiols as agents for lowering intraocular pressure
11/08/2007CA2823724A1 Abnormal cannabidiols as agents for lowering intraocular pressure
11/08/2007CA2771087A1 Use of antisecretory factors for treating intraocular hypertension
11/08/2007CA2650344A1 Use of antisecretory protein to treat intraocular hypertension
11/08/2007CA2649471A1 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
11/08/2007CA2649373A1 Compositions for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders
11/07/2007EP1852420A1 Indole compound and use thereof
11/07/2007EP1852114A1 COMPOSITION CONTAINING DIHOMO-(gamma)-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT
11/07/2007EP1852106A1 Solid ophthalmic drug for external use
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 531